Egetis Therapeutics AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 12, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	2,462	2,110	2,515	1,633	1,524	1,108
Market Cap Growth	122.47%	-16.09%	54.03%	7.15%	37.56%	-10.17%
Enterprise Value	2,394	2,056	2,497	1,550	1,335	939
Last Close Price	5.33	5.34	7.00	5.58	7.10	6.16
Forward PE	18.05	22.61	-	-	-	-
PS Ratio	39.01	33.82	54.55	28.34	67.42	29.00
PB Ratio	9.90	6.23	5.10	2.99	3.01	2.10
P/TBV Ratio	9.98	6.27	5.14	3.02	3.04	2.13
EV/Sales Ratio	37.94	32.96	54.16	26.91	59.07	24.58
Debt / Equity Ratio	0.30	0.25	0.24	0.21	0.01	0.01
Net Debt / Equity Ratio	-0.27	-0.39	-0.47	-0.35	-0.25	-0.26
Net Debt / EBITDA Ratio	0.19	0.40	0.73	0.61	0.64	1.34
Net Debt / FCF Ratio	0.25	0.49	1.03	0.68	0.72	1.07
Asset Turnover	0.10	0.09	0.06	0.09	0.04	0.06
Inventory Turnover	43.28	30.30	13.65	16.92	219.39	50.34
Quick Ratio	0.65	1.01	1.83	3.27	2.80	3.85
Current Ratio	0.69	1.05	1.86	3.33	2.98	3.90
Return on Equity (ROE)	-109.72%	-82.37%	-66.17%	-62.16%	-37.51%	-18.05%
Return on Assets (ROA)	-35.48%	-28.82%	-25.91%	-29.45%	-21.78%	-10.22%
Return on Capital Employed (ROCE)	-119.10%	-82.90%	-54.70%	-47.40%	-38.50%	-19.80%
Earnings Yield	-15.20%	-16.23%	-13.66%	-20.02%	-12.72%	-9.44%
FCF Yield	-10.76%	-12.65%	-9.06%	-17.05%	-11.39%	-11.76%
Buyback Yield / Dilution	-16.70%	-20.10%	-19.57%	-33.86%	-7.97%	-166.96%